Zusammenfassung
Pankreasneoplasien können aus dem exokrinen oder endokrinen Anteil des Organs entstehen. Dieses Kapitel beschränkt sich auf die Tumoren des exokrinen Pankreasanteils. Der häufigste Pankreastumor, das duktale Adenokarzinom, stellt eine besondere Herausforderung dar, da in der Regel die Diagnosestellung im fortgeschrittenen Stadium erfolgt und die therapeutischen Möglichkeiten begrenzt sind.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bartsch D, Rothmund M (1997) Das familiäre exokrine Pankreaskarzinom. Dtsch Med Wochenschr 122: 378–382
Becker N, Wahrendorf J (1998) Krebsatlas der Bundesrepublik Deutschland/Atlas of Cancer Mortality in the Federal Republic of Germany. http://www.dkfz.de
Bruno MJ, Haverkort EB, Tijssen GP et al. (1998) Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 42: 92–96
Burris HA, Moore MJ, Andersen J et al. (1997) Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403–2413
Caraceni A, Portenoy RK (1996) Pain management in patients with pancreatic carcinoma. Cancer 78: 639–653
Diehl SJ, Lehmann KJ, Sadick M et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 206: 373–378
Friess H, Kleeff J, Silva JC et al. (1998) The role of diagnostic laparoscopy in pancreatic and periampullary malignancies. J Am Coll Surg 186: 675–682
Fuchs CS, Colditz GA, Stampfer MJ et al. (1996) A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 156: 2255–2260
Heinemann V, Wilke H, Mergenthaler HG et al. (2000) Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer. Ann Oncol 11: 1399–1403
Hruban RH, Goggins M, Parsons J, Kern SE (2000) Progression model for pancreatic cancer. Clin Cancer Res 6: 2969–2972
Lillemoe KD, Cameron JL, Kaufman HS et al. (1993) Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 217: 447–455
Lowenfels AB, Maisonneuve P, Cavallini G et al. (1993) Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328: 1433–1437
Lowenfels AB, Maisonneuve P, DiMagno EP et al. (1997) Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 89: 442–446
Oettle H, Arning M, Pelzer U et al. (2000) A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer. Ann Oncol 11: 1267–1272
Pedrazzoli S, DiCarlo V, Dionigi R et al. (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Ann Surg 228: 508–517
Rösch T, Braig C, Gain T et al. (1992) Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 102: 188–199
Smith AC, Dowsett JF, Russell RCG et al. (1994) Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 344: 1655–1660
Seiler CA, Wagner M, Sadowski C et al. (2000) Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 4: 443–452
Soetikno RM, Lichtenstein DR, Vandervoort J et al. (1998) Palliation of malignant gastric outlet obstruction using an endoscopically placed wallstent. Gastrointest Endosc 47: 267–270
Sohn TA, Yeo CJ, Cameron JL, Pitt HA et al. (2000) Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg 4: 258–268
Sung JJY, Chung SCS (1995) Endoscopic stenting for palliation of malignant biliary obstruction. A review of progress in the last 15 years. Dig Dis Sci 40: 1167–1173
Trede M, Carter DC (1998) Surgery of the pancreas, 2. ed. Churchill Livingstone, Edinburgh
Trede M, Schwall G, Saeger HD (1990) Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211: 447–458
Warshaw AL, Fernández-del Castillo C (1992) Pancreatic carcinoma. N Engl J Med 326: 455–465
Wiersema MJ, Wiersema LM (1996) Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc 44: 656–662
Wittekind C, Wagner G (1997) TNM-Klassifikation maligner Tumoren. Springer, Heidelberg Berlin New York
Yeo CJ, Tempero MA, Abrams RA (2002) Pancreas cancer: clinical management. In: Kelsen JP, Daly JM, Kern SE et al. (Hrsg) Gastrointestinal oncology: Principles and practice. Lippincott Williams and Wilkins, Philadelphia, p 477–511
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Halm, U., Witzigmann, H. (2005). Pankreasneoplasien. In: Caspary, W.F., Mössner, J., Stein, J. (eds) Therapie gastroenterologischer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26660-7_41
Download citation
DOI: https://doi.org/10.1007/3-540-26660-7_41
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-44174-8
Online ISBN: 978-3-540-26660-0
eBook Packages: Medicine (German Language)